Connealy Pamela Ann — SEC Form 4 filings
SEC reporting owner CIK 1796310. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-25.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-28 to 2026-06-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 88,850 shares, $174,364 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: purchase of 83,400 shares @ $1.96 ($163,464) in Pyxis Oncology, Inc., filed 2024-11-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | CFO & COO | 4 | 2 legs · 88,850 sh · $174,364 | — | 3 |
| Orchestra BioMed Holdings, Inc. (OBIO) | Director | 4 | — | — | 7 |
Form 4 filings — Connealy Pamela Ann
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Grant/award (A): 17,327 @ $0 · Grant/award (A): 21,277 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2025-06-26 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Grant/award (A): 12,422 @ $0 · Grant/award (A): 36,797 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 414,163 (derivative) @ $0.98 | EDGAR |
| 2024-12-23 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 310,000 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | Pyxis Oncology, Inc. (PYXS) | Purchase (P): 5,450 @ $2 · Purchase (P): 83,400 @ $1.96 | EDGAR |
| 2024-06-21 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Grant/award (A): 5,376 @ $0 · Grant/award (A): 17,068 (derivative) @ $0 | EDGAR |
| 2024-03-28 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 328,710 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796310 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →